Advertisement
Screener

LIFE TECHNOLOGIES CORP Form 8-K: Current report, 2013

LIFE TECHNOLOGIES CORP Form 8-K: Current report

Filings on SEC EDGAR, newest first; amendments sit with their base form. Values are as filed.

  • 2013-11-05: Form 8-K; Period of report 2013-11-05; Description 2.02 Results of Operations and Financial Condition; 7.01 Regulation FD Disclosure; Details 2.02.
  • 2013-08-21: Form 8-K; Period of report 2013-08-21; Description 5.07 Submission of Matters to a Vote of Security Holders; Details 5.07.
  • 2013-07-31: Form 8-K; Period of report 2013-07-31; Description 2.02 Results of Operations and Financial Condition; 7.01 Regulation FD Disclosure; Details 2.02.
  • 2013-07-22: Form 8-K; Period of report 2013-07-22; Description 8.01 Other Events; Details 8.01.
FiledFormPeriod of reportDescriptionDetailsDocument
2013-11-058-K2013-11-052.02 Results of Operations and Financial Condition; 7.01 Regulation FD Disclosure2.02 On November 5, 2013, Life Technologies Corporation, or the Company, issued a press release regarding the Company’s financial results for the period ended September 30, 2013.
7.01 See the information set forth under Item 2.02 above and attached as Exhibit 99.1 hereto.
d622777d8k.htm
2013-08-218-K2013-08-215.07 Submission of Matters to a Vote of Security Holders5.07 (a) On August 21, 2013, Life Technologies Corporation (the “Company”) held its Special Meeting of Stockholders (the “Special Meeting”).d586676d8k.htm
2013-07-318-K2013-07-312.02 Results of Operations and Financial Condition; 7.01 Regulation FD Disclosure2.02 On July 31, 2013, Life Technologies Corporation, or the Company, issued a press release regarding the Company’s financial results for the period ended June 30, 2013.
7.01 See the information set forth under Item 2.02 above and attached as Exhibit 99.1 hereto.
d576567d8k.htm
2013-07-228-K2013-07-228.01 Other Events8.01 On July 22, 2013, Life Technologies Corporation (“Life Technologies”) issued a press release announcing that it has filed a definitive proxy statement with the U.S. Securities and Exchange Commission regarding the pending acquisition by Thermo Fisher Scientific Inc. (“Thermo Fisher”) of Life Technologies and has set the date for a special meeting of stockholders to approve the transaction.d552874d8k.htm
2013-06-268-K2013-06-258.01 Other Events8.01 On June 25, 2013, Life Technologies Corporation (the “Company”) issued an announcement to its employees regarding the resignation by Dr. Jonathan Rothberg from his position as the chief executive officer of the Company’s Ion Torrent business to pursue other opportunities.d559599d8k.htm
2013-06-078-K2013-06-078.01 Other Events8.01 In connection with the pending acquisition (the “Acquisition”) of Life Technologies Corporation (the “Company”) by Thermo Fisher Scientific Inc., the Company received on June 7, 2013, a request for additional information and documentary material, often referred to as a “Second Request”, from the United States Federal Trade Commission (the “FTC”) in connection with the FTC’s Hart-Scott-Rodino regulatory review of the Acquisition.d548150d8k.htm
2013-05-028-K2013-05-022.02 Results of Operations and Financial Condition; 7.01 Regulation FD Disclosure2.02 On May 2, 2013, Life Technologies Corporation, or the Company, issued a press release regarding the Company’s financial results for the period ended March 31, 2013.
7.01 See the information set forth under Item 2.02 above and attached as Exhibit 99.1 hereto.
d530630d8k.htm
2013-04-248-K2013-04-245.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers; 5.07 Submission of Matters to a Vote of Security Holders5.02 In conjunction with the Annual Meeting of Stockholders (the “Annual Meeting”) of Life Technologies Corporation (the “Company”) held on April 24, 2013, Arnold J. Levine, Ph.D. retired from the Board of Directors (the “Board”) immediately following the Annual Meeting in accordance with the retirement policy set forth in the Company’s Corporate Governance Principles, which provides that the Board only nominate directors who will be 72 years of age or younger on the date of election.
5.07 (a) On April 24, 2013, the Company held its Annual Meeting.
d526364d8k.htm
2013-04-168-K2013-04-141.01 Entry into a Material Definitive Agreement1.01 Entry into a Material Definitive Agreement.d522428d8k.htm
2013-04-158-K2013-04-158.01 Other Events8.01 On April 15, 2013, Life Technologies Corporation (the “Company”) and Thermo Fisher Scientific Inc. (“Thermo Fisher”) issued a joint press release announcing the execution of an Agreement and Plan of Merger, pursuant to which, among other things and subject to the satisfaction or waiver of specified conditions, Thermo Fisher agreed to acquire the Company in an all cash transaction.d521689d8k.htm
2013-02-048-K2013-02-042.02 Results of Operations and Financial Condition; 7.01 Regulation FD Disclosure2.02 On February 4, 2013, Life Technologies Corporation, or the Company, issued a press release regarding the Company’s financial results for the period ended December 31, 2012.
7.01 See the information set forth under Item 2.02 above and attached as Exhibit 99.1 hereto.
d479703d8k.htm